Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
Baglin
T
T
Beacham
E
E
D000368:Aged; D002648:Child; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007223:Infant; D007518:Isoantibodies / Q000096:biosynthesis*; D008875:Middle Aged; D012307:Risk Factors; D013997:Time Factors
D007518:Isoantibodies; D005169:Factor VIII